Brand-name pharmaceutical manufacturers have grappled in recent years with one of the largest waves of drug patent expirations in history. As this so-called patent cliff occurred, many blockbuster drugs lost patent exclusivity, allowing low-price generic drugs to inundate the market. As a result, many brand-name pharmaceutical manufacturers have dealt with intensifying competition from generic manufacturers, cutting into revenue growth. In the coming years, brand-name pharmaceutical manufacturers will exhibit growth due to strong consumer demand for biologic drugs.
Pharmaceutical manufacturers develop prescription and over-the-counter products that are used to prevent or treat illnesses in humans or animals. Brand-name drugs and medication have patent protection. This industry does not include nutritional supplement or cosmetic product manufacturers.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.